ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 67 filers reported holding ALBIREO PHARMA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $23,490 | +11.6% | 1,087 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $21,044 | -2.5% | 1,087 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $21,588 | -33.4% | 1,087 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $32,425 | -69.4% | 1,087 | -76.1% | 0.00% | 0.0% |
| Q4 2021 | $106,039 | -25.4% | 4,553 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $142,054 | -11.3% | 4,553 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $160,175 | -0.2% | 4,553 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $160,493 | -6.0% | 4,553 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $170,783 | +19.2% | 4,553 | +6.0% | 0.00% | 0.0% |
| Q3 2020 | $143,324 | +26.0% | 4,295 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $113,775 | +102.7% | 4,295 | +25.3% | 0.00% | +100.0% |
| Q1 2020 | $56,116 | -35.6% | 3,428 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $87,140 | +30.9% | 3,428 | +3.0% | 0.00% | 0.0% |
| Q3 2019 | $66,560 | -38.0% | 3,328 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $107,295 | +0.1% | 3,328 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $107,195 | +31.3% | 3,328 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $81,636 | -25.6% | 3,328 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $109,691 | -99.9% | 3,328 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $118,145,000 | – | 3,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 174,791 | $6,556,000 | 3.03% |
| Sio Capital Management, LLC | 354,210 | $13,286,000 | 2.72% |
| Birchview Capital, LP | 92,000 | $3,451,000 | 1.99% |
| Chicago Capital, LLC | 618,263 | $23,191,000 | 1.04% |
| Perceptive Advisors | 2,360,139 | $88,529,000 | 0.95% |
| Endurant Capital Management LP | 42,292 | $1,586,000 | 0.57% |
| Artal Group S.A. | 700,000 | $26,257,000 | 0.56% |
| Cormorant Asset Management, LP | 500,000 | $18,755,000 | 0.45% |
| Samsara BioCapital, LLC | 100,000 | $3,751,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 257,372 | $9,654,000 | 0.34% |